Items Tagged ‘trifluridine’

September 30th, 2015

Lonsurf® Approved for the Treatment of Colorectal Cancer


The United States Food and Drug Administration (FDA) has approved the oral agent, Lonsurf® (trifluridine and tipiracil), for the treatment of colorectal cancer. Colorectal cancer remains the second leading cause of cancer-related deaths in the U.S. although death rates from colorectal cancer have declined in the past 10 years which is thought to be due […]

View full entry

Tags: advanced, Colon Cancer, colorectal cancer, fda, Lonsurf, News, Rectal Cancer, Stage IV (D)/Relapsed Colon Cancer, Stage IV Rectal Cancer, tipiracil, trifluridine